The Distribution of Incomplete Gastric Intestinal Metaplasia (GIM) Subtype among Biopsy Sites according to the Updated Sydney System and Its Association with GIM Extension

Dynamics ofHelicobacter pyloriinfection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial

(2017) Robertino M Mera et al.   GUT

Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study

(2016) Dan Li et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System

(2016) Kavya M. Reddy et al.   Clinical Gastroenterology and Hepatology

Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study

(2016) Carlos A. González et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Kyoto global consensus report onHelicobacter pylorigastritis

(2015) Kentaro Sugano et al.   GUT

Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population

(2015) Huan Song et al.   BMJ-British Medical Journal

Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population

(2015) Huan Song et al.   BMJ-British Medical Journal

Prevalence of gastric precancerous conditions

(2014) Luís Marques-Silva et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

(2011) M. Dinis-Ribeiro et al.   ENDOSCOPY